Pazopanib as Single Agent in Advanced NETs

Clinical trial NCT01280201 · COMPLETED

Trial details

NCT number: NCT01280201
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced/Metastatic Neuroendocrine Tumors

Start date: 2011-01-26
Primary completion: 2013-04-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.